Intelligent Bio Solutions Inc.
INBS
$4.00
-$0.02-0.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.58M | 3.29M | 3.05M | 2.94M | 3.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.58M | 3.29M | 3.05M | 2.94M | 3.03M |
| Cost of Revenue | 1.93M | 1.87M | 1.81M | 1.21M | 1.47M |
| Gross Profit | 1.66M | 1.42M | 1.25M | 1.73M | 1.56M |
| SG&A Expenses | 10.12M | 9.59M | 8.88M | 8.84M | 8.85M |
| Depreciation & Amortization | 1.19M | 1.21M | 1.21M | 1.19M | 1.21M |
| Other Operating Expenses | -823.20K | -884.10K | -816.90K | -510.90K | -421.40K |
| Total Operating Expenses | 14.36M | 13.73M | 13.48M | 13.29M | 13.79M |
| Operating Income | -10.78M | -10.44M | -10.42M | -10.35M | -10.76M |
| Income Before Tax | -11.33M | -10.91M | -10.60M | -10.30M | -10.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.33 | -10.91 | -10.60 | -10.30 | -10.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 40.60K | 38.90K | 36.10K | 34.70K | 36.70K |
| Net Income | -11.29M | -10.87M | -10.57M | -10.26M | -10.70M |
| EBIT | -10.78M | -10.44M | -10.42M | -10.35M | -10.76M |
| EBITDA | -9.71M | -9.33M | -9.33M | -9.28M | -9.65M |
| EPS Basic | -15.13 | -17.27 | -20.83 | -25.57 | -35.48 |
| Normalized Basic EPS | -9.03 | -10.38 | -12.79 | -15.95 | -22.13 |
| EPS Diluted | -15.13 | -17.27 | -20.83 | -25.59 | -35.50 |
| Normalized Diluted EPS | -9.03 | -10.38 | -12.79 | -15.95 | -22.13 |
| Average Basic Shares Outstanding | 3.08M | 2.59M | 2.11M | 1.72M | 1.35M |
| Average Diluted Shares Outstanding | 3.08M | 2.59M | 2.11M | 1.72M | 1.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |